Literature DB >> 19846822

Accuracy of urine cytology and the significance of an atypical category.

Fadi Brimo1, Robin T Vollmer, Bruce Case, Armen Aprikian, Wassim Kassouf, Manon Auger.   

Abstract

The "atypical urothelial cell" cytologic category is nonstandardized. We subclassify atypical cases to "atypical, favor a reactive process" or "atypical, unclear if reactive or neoplastic." We evaluated the predictive significance of atypical cases by looking at their histologic follow-up. Among the 1,114 patients and 3,261 specimens included, 282 specimens had histologic follow-up. An atypical diagnosis did not carry a significant increased risk of urothelial neoplasia compared with the benign category. Although an "atypical unclear" diagnosis carried a higher rate of detection of high-grade cancer on follow-up biopsy in comparison with "atypical reactive" or "negative" diagnoses (26/58 [45%] vs 15/52 [29%] and 16/103 [15.5%], respectively), this difference was not statistically significant. These results suggest that dividing atypical cases into 2 categories based on the level of cytologic suspicion of cancer does not add clinically relevant information within the atypical category. They also raise the question of the significance of the atypical category altogether.

Entities:  

Mesh:

Year:  2009        PMID: 19846822     DOI: 10.1309/AJCPPRZLG9KT9AXL

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  22 in total

1.  Prognostic value of urinary cytology and other biomarkers for recurrence and progression in bladder cancer: a prospective study.

Authors:  Michael D Bell; Faysal A Yafi; Fadi Brimo; Jordan Steinberg; Armen G Aprikian; Simon Tanguay; Wassim Kassouf
Journal:  World J Urol       Date:  2016-02-23       Impact factor: 4.226

2.  Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy.

Authors:  Philip H Kim; Ranjit Sukhu; Billy H Cordon; John P Sfakianos; Daniel D Sjoberg; A Ari Hakimi; Guido Dalbagni; Oscar Lin; Harry W Herr
Journal:  BJU Int       Date:  2014-02-14       Impact factor: 5.588

3.  Spontaneous rupture of the ureter.

Authors:  Alper Eken; Tugana Akbas; Taner Arpaci
Journal:  Singapore Med J       Date:  2015-02       Impact factor: 1.858

Review 4.  Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer.

Authors:  Mahul B Amin; Steven C Smith; Victor E Reuter; Jonathan I Epstein; David J Grignon; Donna E Hansel; Oscar Lin; Jesse K McKenney; Rodolfo Montironi; Gladell P Paner; Hikmat A Al-Ahmadie; Ferran Algaba; Syed Ali; Isabel Alvarado-Cabrero; Lukas Bubendorf; Liang Cheng; John C Cheville; Glen Kristiansen; Richard J Cote; Brett Delahunt; John N Eble; Elizabeth M Genega; Christian Gulmann; Arndt Hartmann; Cord Langner; Antonio Lopez-Beltran; Cristina Magi-Galluzzi; Jorda Merce; George J Netto; Esther Oliva; Priya Rao; Jae Y Ro; John R Srigley; Satish K Tickoo; Toyonori Tsuzuki; Saleem A Umar; Theo Van der Kwast; Robert H Young; Mark S Soloway
Journal:  Mod Pathol       Date:  2014-11-21       Impact factor: 7.842

5.  Diagnostic significance of atypical category in the voided urine samples: A retrospective study in a tertiary care center.

Authors:  Ghadeer A Mokhtar; Mohamed Al-Dousari; Doaa Al-Ghamedi
Journal:  Urol Ann       Date:  2010-09

6.  A novel precision-engineered microfiltration device for capture and characterisation of bladder cancer cells in urine.

Authors:  Marc Birkhahn; Anirban P Mitra; Anthony J Williams; Nancy J Barr; Eila C Skinner; John P Stein; Donald G Skinner; Yu-Chong Tai; Ram H Datar; Richard J Cote
Journal:  Eur J Cancer       Date:  2013-07-09       Impact factor: 9.162

7.  Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA.

Authors:  Jonathan C Dudley; Joseph Schroers-Martin; Daniel V Lazzareschi; William Y Shi; Simon B Chen; Mohammad S Esfahani; Dharati Trivedi; Jacob J Chabon; Aadel A Chaudhuri; Henning Stehr; Chih Long Liu; Harumi Lim; Helio A Costa; Barzin Y Nabet; Mandy L Y Sin; Joseph C Liao; Ash A Alizadeh; Maximilian Diehn
Journal:  Cancer Discov       Date:  2018-12-21       Impact factor: 39.397

8.  The influence of urine cytology on our practice.

Authors:  Mahmoud Alameddine; Anmar Nassir
Journal:  Urol Ann       Date:  2012-05

9.  APE1/Ref-1 as a Serological Biomarker for the Detection of Bladder Cancer.

Authors:  Ju Hyun Shin; Sunga Choi; Yu Ran Lee; Myoung Soo Park; Yong Gil Na; Kaikobad Irani; Sang Do Lee; Jin Bong Park; Jin Man Kim; Jae Sung Lim; Byeong Hwa Jeon
Journal:  Cancer Res Treat       Date:  2015-01-02       Impact factor: 4.679

10.  Evaluation of a triple combination of cytokeratin 20, p53 and CD44 for improving detection of urothelial carcinoma in urine cytology specimens.

Authors:  Brent Arville; Emily O'Rourke; Fai Chung; Mahul Amin; Shikha Bose
Journal:  Cytojournal       Date:  2013-12-27       Impact factor: 2.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.